RENO, Nevada. – May 17, 2022 – A major new installation by Bruker is enabling sustainable energy leader, US-based Dragonfly Energy, to accelerate its pioneering battery technology research with a differentiated high performance in-house research facility. Dedicated to lithium and next-generation solid-state battery optimization, the site features a range of high-tech analytical instrumentation to help drive the global conversion to renewable energy.
Dragonfly Energy has invested in the new facility in response to rapid growth in demand for its sustainable battery technology. Its research focuses on developing non-toxic lithium batteries in a solvent-free process and on exploring new innovations within its patented solid-state cell technology, for high grade, renewable energy storage.
Dr. Denis Phares, co-founder and CEO at Dragonfly Energy
Dr. Mark Munch, President of the Bruker Nano Group
US-based Dragonfly Energy is a leader in lithium-ion deep cycle batteries, making renewable energy accessible and affordable. Its revolutionary, non-toxic deep cycle lithium-ion batteries are displacing lead acid batteries in vehicles, vessels, and material handling. The future of Dragonfly is high-grade renewable energy storage through the deployment of its proprietary and patented solid-state cell technology. For more information, visit DragonflyEnergy.com.
Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular and cell biology research, in applied and pharma applications, in microscopy and nanoanalysis, as well as in industrial applications. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit: https://www.bruker.com/.